Observational Study of Meloxicam in Any Labeled Indication

• Status: Completed
• Trial end date: 1969-12-31
• Target enrollment: 0
• Participant gender: All

Summary

Evaluation on the amelioration of symptom intensity of the indication and to evaluate drug tolerability.

• Accepts Healthy Volunteers?: No

Details

• Lead Sponsor: Boehringer Ingelheim
• Treatments: Meloxicam

Criteria

Inclusion Criteria:

• Patients according to the physicians medical criteria on the labeled indications for Meloxicam

Exclusion Criteria:

• none